Q-omics provides the consensus-scored CT45A8 profile across patient tissues and cancer cell-line models. Additionally, CT45A8 RNA expression shows 158 significant gene co-expression associations, with the highest sampling consensus in KIRC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for CT45A8 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with CT45A8 in patient tissues and cancer cell lines. In patient samples, CT45A8 shows the broadest associations at the RNA and protein expression levels, with KIRC recurring as the lineage with the largest associated feature set. In cancer cell lines, CT45A8 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BREAST, while CRISPR and shRNA rows add functional-dependency signals in LUNG_NSCLC_LUAD and CNS.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	158	KIRC (158)	view →
Mutation	20	KIRC (20)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
shRNA	867	BREAST (137)	view →
CRISPR	825	LUNG_NSCLC_LUAD (153)	view →
▼RNA
RNA	636	CNS (149)	view →
shRNA	197	BLOOD_Lymphoma (61)	view →